Cargando…

Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins

Epigenetic dysregulation, particularly alterations in DNA methylation and hydroxymethylation, plays a pivotal role in cancer initiation and progression. Ten-eleven translocation (TET) proteins catalyze the successive oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and further o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyejin, Jung, Inkyung, Lee, Chan Hyeong, An, Jungeun, Ko, Myunggon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671484/ https://www.ncbi.nlm.nih.gov/pubmed/38003566 http://dx.doi.org/10.3390/ijms242216375

Ejemplares similares

Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy
por: Jung, Inkyung, et al.
Publicado: (2023)

Loss of adipose TET proteins enhances β-adrenergic responses and protects against obesity by epigenetic regulation of β3-AR expression
por: Byun, Seongjun, et al.
Publicado: (2022)

Functions of TET Proteins in Hematopoietic Transformation
por: Han, Jae-A, et al.
Publicado: (2015)

TET family dioxygenases and DNA demethylation in stem cells and cancers
por: An, Jungeun, et al.
Publicado: (2017)

Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation
por: An, Jungeun, et al.
Publicado: (2023)

Acute loss of TET function results in aggressive myeloid cancer in mice
por: An, Jungeun, et al.
Publicado: (2015)

Editorial for the Special Issue “Molecular Mechanism of Leukemia”
por: An, Jungeun, et al.
Publicado: (2023)

Inducible disruption of Tet genes results in myeloid malignancy, readthrough transcription, and a heterochromatin-to-euchromatin switch
por: Yuita, Hiroshi, et al.
Publicado: (2023)

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
por: Ko, Myunggon, et al.
Publicado: (2010)

TET-Mediated Epigenetic Regulation in Immune Cell Development and Disease
por: Tsiouplis, Nikolas James, et al.
Publicado: (2021)

Epigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesis
por: Chen, Hsiao-Fan, et al.
Publicado: (2016)

The “epiTet” of Air Pollution: Epigenetic Regulation of Airway Inflammation by Tet1
por: Ji, Hong, et al.
Publicado: (2023)

Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma
por: Gong, Fuxing, et al.
Publicado: (2016)

Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration
por: Liu, Jun, et al.
Publicado: (2020)

TET Proteins in the Spotlight: Emerging Concepts of Epigenetic Regulation in T Cell Biology
por: Tsagaratou, Ageliki
Publicado: (2023)

Epigenetic dysregulation of TET2 in human glioblastoma
por: García, María G., et al.
Publicado: (2018)

DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells
por: Zhang, Xiaotian, et al.
Publicado: (2016)

Epigenetic Regulation of Corneal Epithelial Differentiation by TET2
por: Sasamoto, Yuzuru, et al.
Publicado: (2023)

Tet protein function during Drosophila development
por: Wang, Fei, et al.
Publicado: (2018)

Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylation
por: Gödecke, Natascha, et al.
Publicado: (2017)

TET1 is a beige adipocyte-selective epigenetic suppressor of thermogenesis
por: Damal Villivalam, Sneha, et al.
Publicado: (2020)

Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes
por: Kao, Shih-Han, et al.
Publicado: (2016)

TET2 as an epigenetic master regulator for normal and malignant hematopoiesis
por: Nakajima, Hideaki, et al.
Publicado: (2014)

Association of TET3 epigenetic inactivation with head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Engineered Split-TET2 Enzyme for Inducible Epigenetic Remodeling
por: Lee, Minjung, et al.
Publicado: (2017)

Role of TET1-mediated epigenetic modulation in Alzheimer’s disease
por: Armstrong, Matthew J., et al.
Publicado: (2023)

Development of a novel program for conversion from tetrahedral‐mesh‐based phantoms to DICOM dataset for radiation treatment planning: TET2DICOM
por: Cheon, Bo‐Wi, et al.
Publicado: (2021)

The HDAC7–TET2 epigenetic axis is essential during early B lymphocyte development
por: Azagra, Alba, et al.
Publicado: (2022)

Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins
por: Pirola, Carlos J., et al.
Publicado: (2015)

Epigenetic regulation of intestinal stem cells by Tet1-mediated DNA hydroxymethylation
por: Kim, Rinho, et al.
Publicado: (2016)

O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins
por: Dehennaut, Vanessa, et al.
Publicado: (2014)

Epigenetic reprogramming by TET enzymes impacts co-transcriptional R-loops
por: Sabino, João C, et al.
Publicado: (2022)

Epigenetic Targets in Schizophrenia Development and Therapy
por: Wawrzczak-Bargieła, Agnieszka, et al.
Publicado: (2023)

Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
por: Shenoy, N, et al.
Publicado: (2017)

Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma
por: Yamashita, Hironori, et al.
Publicado: (2021)

Oocyte TET3: an epigenetic modifier responsible for maternal inheritance of glucose intolerance
por: Jiang, Xiaoxue, et al.
Publicado: (2022)

Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers
por: Li, Lili, et al.
Publicado: (2016)

Loss of TET2 and TET3 in regulatory T cells unleashes effector function
por: Yue, Xiaojing, et al.
Publicado: (2019)

Epigenetic drug screen identified IOX1 as an inhibitor of Th17-mediated inflammation through targeting TET2
por: Hu, Xiao, et al.
Publicado: (2022)

Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ftdug9g1226ve8e312ill8sfco